Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab

Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab

Concomitant medications may alter the effect of biological therapy in inflammatory bowel disease. The aim was to investigate the effect of proton pump inhibitors on remission rates in patients with inflammatory bowel disease treated with the gut-selective vedolizumab. Patients from the Hungarian nat...

Full description

Bibliographic Details
Main Authors: Kata Szemes, Nelli Farkas, Zoltan Sipos, Renata Bor, Anna Fabian, Zoltan Szepes, Klaudia Farkas, Tamas Molnar, Eszter Schafer, Tamas Szamosi, Agnes Salamon, Aron Vincze, Patricia Sarlos
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
proton pump inhibitor
vedolizumab
inflammatory bowel disease
Online Access:https://www.mdpi.com/2227-9059/12/1/158

Internet

https://www.mdpi.com/2227-9059/12/1/158

Similar Items